EACH-Registry: An European Registry for Acquired Hemophilia

2006 ◽  
pp. 42-43
Author(s):  
A. Huth-Kühne ◽  
P. Lages ◽  
R. Fischer ◽  
R. Zimmermann
2020 ◽  
Author(s):  
R Maselli ◽  
R Palma ◽  
M Traina ◽  
A Granata ◽  
D Juzgado ◽  
...  

2003 ◽  
Vol 65 (3) ◽  
pp. 223-226 ◽  
Author(s):  
Masahide YAMAGUCHI ◽  
Mamoru KOHDA ◽  
Hiroaki UEKI ◽  
Wataru FUJIMOTO

2009 ◽  
Vol 2 (2) ◽  
pp. 29-32 ◽  
Author(s):  
Antonio Coppola ◽  
Mirko Di Capua ◽  
Matteo Nicola Dario Di Minno ◽  
Anna Maria Cerbone

Author(s):  
Michael Esteves Pereira ◽  
Christoph Bocksrucker ◽  
Johanna Anna Kremer Hovinga ◽  
Martin Mueller ◽  
Michael Daskalakis ◽  
...  

2020 ◽  
Vol 34 (2) ◽  
pp. 233-239 ◽  
Author(s):  
Seshadri Sriprasad ◽  
Mohammed Aldiwani ◽  
Shiv Pandian ◽  
Tommy K. Nielsen ◽  
Mohamed Ismail ◽  
...  

2017 ◽  
Vol 2017 ◽  
pp. 1-7 ◽  
Author(s):  
Quentin Binet ◽  
Catherine Lambert ◽  
Laurine Sacré ◽  
Stéphane Eeckhoudt ◽  
Cedric Hermans

Background. Acquired hemophilia A (AHA) is a rare condition, due to the spontaneous formation of neutralizing antibodies against endogenous factor VIII. About half the cases are associated with pregnancy, postpartum, autoimmune diseases, malignancies, or adverse drug reactions. Symptoms include severe and unexpected bleeding that may prove life-threatening.Case Study. We report a case of AHA associated with bullous pemphigoid (BP), a chronic, autoimmune, subepidermal, blistering skin disease. To our knowledge, this is the 25th documented case of such an association. Following treatment for less than 3 months consisting of methylprednisolone at decreasing dose levels along with four courses of rituximab (monoclonal antibody directed against the CD20 protein), AHA was completely cured and BP well-controlled.Conclusions. This report illustrates a rare association of AHA and BP, supporting the possibility of eradicating the inhibitor with a well-conducted short-term treatment.


Sign in / Sign up

Export Citation Format

Share Document